0001477932-21-003495.txt : 20210524
0001477932-21-003495.hdr.sgml : 20210524
20210524084823
ACCESSION NUMBER: 0001477932-21-003495
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210521
FILED AS OF DATE: 20210524
DATE AS OF CHANGE: 20210524
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Davidson Robert Steven
CENTRAL INDEX KEY: 0001412747
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-55908
FILM NUMBER: 21951362
MAIL ADDRESS:
STREET 1: 7633 E. 63RD PLACE, #220
CITY: TULSA
STATE: OK
ZIP: 74133
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cure Pharmaceutical Holding Corp.
CENTRAL INDEX KEY: 0001643301
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 371765151
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1620 BEACON PLACE
CITY: OXNARD
STATE: CA
ZIP: 93033
BUSINESS PHONE: 805-824-0410
MAIL ADDRESS:
STREET 1: 1620 BEACON PLACE
CITY: OXNARD
STATE: CA
ZIP: 93033
FORMER COMPANY:
FORMER CONFORMED NAME: Makkanotti Group Corp.
DATE OF NAME CHANGE: 20150526
4
1
form4.xml
FORM 4
X0306
4
2021-05-21-05:00
false
0001643301
Cure Pharmaceutical Holding Corp.
CURR
0001412747
Davidson Robert Steven
1620 BEACON PLACE
OXNARD
CA
93022
true
true
false
false
Chief Executive Officer
Common Stock
2021-05-21-05:00
4
P
false
7400
0.709
A
549756
D
This is the weighted average purchase price. Shares were purchased in multiple transactions at prices from $0.70000 to $0.71950. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnote (1) to this Form 4. The amount reflected has been rounded to 3 decimal points.
/s/ Robert Davidson
2021-05-24-05:00